Sort by
Refine Your Search
-
engaged in developing the physical foundations for a future fusion power plant. The institute is affiliated to the European Fusion Programme. The Max Planck Institute for Plasma Physics in Garching offers
-
for Molecular Medicine in the Helmholtz Association, founded in 1992, today inspiring and nurturing a diverse talent pool of 1,800 people from over 70 countries. We are 90 percent funded by the German federal
-
Postdoc (f/m/d) Research Data Management and Data Visualization / Completed university studies (P...
and High Performance Computing for automated processing, then use the results to implement the automated data and model processing in the project # Track metadata from input data and from processing
-
electrophysiological and calcium imaging recording techniques to assess glia and neural activities. Perform pharmacological modulation to investigate neural circuit activity in the context of metabolism and energy
-
, maintenance, and data analysis. Strong background in MS-based proteomics data analysis and familiarity with modern computational tools. Additional experience in high-throughput proteomics, low-input proteomics
-
„Research for a life without cancer“ is our mission at the German Cancer Research Center. We investigate how cancer develops, identify cancer risk factors and look for new cancer prevention
-
the development of computational methods for genetics, high-throughput omics data and causal discovery. Our interdisciplinary and international team is jointly located at DKFZ and EMBL Heidelberg, and
-
-Tissue grant , and performed in close collaboration with the Deo group at EMBL, the Gigan/deAguiar groups in Paris and the Stiel lab in Munich. The successful candidate is expected to take a strong lead
-
programming and repair, bioengineering, and computational health. We particularly excel in the fields of basic research, bioengineering, artificial intelligence, and technological development. Through
-
); Chao et al., Nat Immunol, 2023 (https://www.nature.com/articles/s41590-022-01386-w ); Soll et al., Nat Immunol, 2024). We use novel cutting-edge technologies in the area of high-dimensional single-cell